Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
KKR $590 million subordinated notes offering
The investment-grade notes are due 2065
Pampa Energía $340 million notes offering
The 7.875% notes are due 2034
Strive Enterprises / Asset Entities $750 million committed PIPE financing
We advised Strive Enterprises on the transaction involving common stock, pre-funded warrants and traditional warrants
NatWest Group $1.55 billion senior notes offering
We advised NatWest Group on the SEC-registered offering
QXO $1.495 billion common and depositary share offerings
The common stock is listed on the NYSE
Hinge Health $503 million IPO
The shares are listed on the New York Stock Exchange
Mirion Technologies $400 million convertible senior notes offering
We advised Mirion Technologies on the offering
Avolta €500 million notes offering
We advised Avolta on its high-yield notes offering
Texas Instruments $1.2 billion notes offering
We advised Texas Instruments on its investment-grade debt offering
Kenvue $750 million senior notes offering
The investment-grade notes are due 2032